2398. Utilization Practices of Ceftazidime–Avibactam at Academic Medical Centers in the United States

BACKGROUND: Ceftazidime–avibactam (CAV) was US FDA-approved for complicated intra-abdominal/urinary tract infections in 2015, and for hospital-acquired/ventilator-associated pneumonia in 2018. However, little is known about its real-world use. METHODS: Encounters of inpatients receiving CAV at acade...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Strich, Jeffrey R, Ricotta, Emily, Lai, Yi Ling, Hohmann, Samuel, Hussain, Sadia, Rhee, Chanu, Klompas, Michael, Palmore, Tara N, III, John H Powers, Dekker, John P, Adjemian, Jennifer, Danner, Robert L, Kadri, Sameer S
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253798/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados